Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Major Depressive Disorder Adjunctive Therapy Investigational Medication Study
Clinical Trial Protocol ID
13060605

Clinical Trial Investigator Name
Corey Goldstein

Clinical Trial Title

A Phase 3, Double-Blind, Placebo-Controlled Study of an Investigational Medication as Adjunctive Therapy in Major Depressive Disorder



Clinical Trial Protocol Description

This is an 18- to 19-week study in patients with major depressive disorder who have an inadequate response to certain other antidepressants. The study will include a one- to two-week screening period, followed by an eight-week, open-label period of treatment with an antidepressant, followed by an eight-week, double-blind treatment period with the investigational medication or placebo added to the antidepressant therapy, followed by a one-week safety follow-up period. A 26-week open-label extension study may also be available to those who complete the lead-in study.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are 18-65 years of age
  • Have major depressive disorder, with current episode lasting between two and 12 months
  • Have failure to an adequate trial of an antidepressant during the current depressive episode


You will be excluded from this study if you:

  • Have certain other diagnoses
  • Have a history of ECT and/or certain other treatments during the current episode or within 6 months of study
  • Have current, or history of, substance use or dependence
  • Have certain other medical conditions
  • Have current, or history of, cataracts, eye surgery, laser treatment

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.





Contact Name Treatment Research Center
Contact Phone (312) 942-6597
Promotional Information

Clinical Trials Home
Mental Health Trials
Major Depressive Disorder Adjunctive Therapy Investigational Medication Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois